D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.
about
Immunomodulatory Effects Mediated by DopamineDopamine receptor D2 is correlated with gastric cancer prognosis.DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Repurposing the antipsychotic trifluoperazine as an antimetastasis agent.Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases.Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer.Dopamine, T cells and multiple sclerosis (MS).Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.Potential Roles of Peripheral Dopamine in Tumor Immunity.N-Octanoyl dopamine transiently inhibits T cell proliferation via G1 cell-cycle arrest and inhibition of redox-dependent transcription factors.Different effects of bortezomib on the expressions of various protein kinase C isoenzymes in T cells of patients with systemic lupus erythematosus and in Jurkat cells.Peripheral Dopamine in Restless Legs Syndrome.The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
P2860
Q28071580-03F86D79-C1B7-4273-8D2B-0146639BE66AQ33599147-9CF93CFB-CF3B-4EFE-B6C2-C6AA6D07C420Q34508840-C54DE58E-090A-42D5-9E96-98E6CD06A7E0Q35000860-237BA6D3-D0DD-4025-9871-3ABDE4DDDE2AQ35536672-02C67E87-AA9B-4C48-AEBD-DBF8AC985F0CQ36696931-0A32F15D-4657-4EBE-B163-F682F2C19A0BQ38366498-1C863F46-AFA8-4ABB-BD5C-95562AAEAF98Q38544976-782585AD-E4E4-49F9-9FE5-7C406D983093Q38863202-D1315316-7D89-4562-87B1-E543F9E54426Q39173551-2961A23F-7D1E-46DE-931D-87B21EC7A085Q41229954-140C1D31-E94E-4527-BD1D-71BE4ABB7986Q41721674-BB889BA6-CBA2-4C98-84FA-ABE42A39E816Q42010223-1AF03BB0-6700-4E21-B9CE-E8AADC64ED92Q53975226-DE6F35F4-5B78-4D62-B519-AE4D2BE20C3FQ54969192-BB7222CC-B3C7-4AFF-A96D-7C91A54BBCEDQ57476258-6F88C4CB-7E5D-44F0-96D9-9FC6A64E7FD1
P2860
D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@ast
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@en
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@nl
type
label
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@ast
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@en
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@nl
prefLabel
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@ast
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@en
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@nl
P2093
P2860
P356
P1476
D1 and D2 dopamine receptor-me ...... st in jurkat T leukemic cells.
@en
P2093
Biswarup Basu
Chandrani Sarkar
Debanjan Chakroborty
Partha Sarathi Dasgupta
Saurav Shome
Subhalakshmi Ganguly
Sujit Basu
P2860
P304
27026-27032
P356
10.1074/JBC.M110.144022
P407
P577
2010-06-30T00:00:00Z